Global Rheumatoid Arthritis Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 13-Oct-2022
No. of pages: 124

The report focuses on the Rheumatoid Arthritis Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Rheumatoid Arthritis Drugs market.

Major Players in the Rheumatoid Arthritis Drugs market are:

AbbVie Inc.

Johnson & Johnsons Services, Inc

Celltrion Inc.

Bristol-Myers Squibb Company

Celegene Corporations

Biogen Inc.

MedImmune, LLC

F. Hoffmann-La Roche Ltd.

Takeda Pharmaceutical Company Ltd.

Amgen Inc.

Boehringer Ingelheim GmbH

Pfizer, Inc.

On the basis of types, the Rheumatoid Arthritis Drugs market is primarily split into:

Disease-Modifying Anti-Rheumatic Drugs (DMARDs)

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Corticosteroids

Uric Acid Drugs

Others

On the basis of applications, the market covers:

Prescription-Based Drugs

Over-the-Counter Drugs

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Rheumatoid Arthritis Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Rheumatoid Arthritis Drugs Market Overview
1.1 Product Overview and Scope of Rheumatoid Arthritis Drugs Market
1.2 Rheumatoid Arthritis Drugs Market Segment by Type
1.2.1 Global Rheumatoid Arthritis Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Rheumatoid Arthritis Drugs Market Segment by Application
1.3.1 Rheumatoid Arthritis Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Rheumatoid Arthritis Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Rheumatoid Arthritis Drugs (2017-2029)
1.5.1 Global Rheumatoid Arthritis Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Rheumatoid Arthritis Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Rheumatoid Arthritis Drugs Industry
1.7 Impact of Carbon Neutrality on the Rheumatoid Arthritis Drugs Industry

2 Rheumatoid Arthritis Drugs Market Upstream and Downstream Analysis
2.1 Rheumatoid Arthritis Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Rheumatoid Arthritis Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 AbbVie Inc.
3.1.1 AbbVie Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Johnson & Johnsons Services, Inc
3.2.1 Johnson & Johnsons Services, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Celltrion Inc.
3.3.1 Celltrion Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Bristol-Myers Squibb Company
3.4.1 Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Celegene Corporations
3.5.1 Celegene Corporations Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Biogen Inc.
3.6.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 MedImmune, LLC
3.7.1 MedImmune, LLC Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 F. Hoffmann-La Roche Ltd.
3.8.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Takeda Pharmaceutical Company Ltd.
3.9.1 Takeda Pharmaceutical Company Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Amgen Inc.
3.10.1 Amgen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Boehringer Ingelheim GmbH
3.11.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Pfizer, Inc.
3.12.1 Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 Rheumatoid Arthritis Drugs Market Performance (2017-2022)
3.12.4 Business Overview

4 Global Rheumatoid Arthritis Drugs Market Landscape by Player
4.1 Global Rheumatoid Arthritis Drugs Sales and Share by Player (2017-2022)
4.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Rheumatoid Arthritis Drugs Average Price by Player (2017-2022)
4.4 Global Rheumatoid Arthritis Drugs Gross Margin by Player (2017-2022)
4.5 Rheumatoid Arthritis Drugs Market Competitive Situation and Trends
4.5.1 Rheumatoid Arthritis Drugs Market Concentration Rate
4.5.2 Rheumatoid Arthritis Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Rheumatoid Arthritis Drugs Sales, Revenue, Price Trend by Type
5.1 Global Rheumatoid Arthritis Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Rheumatoid Arthritis Drugs Price by Type (2017-2022)
5.4 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate of Disease-Modifying Anti-Rheumatic Drugs (DMARDs) (2017-2022)
5.4.2 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2017-2022)
5.4.3 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate of Corticosteroids (2017-2022)
5.4.4 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate of Uric Acid Drugs (2017-2022)
5.4.5 Global Rheumatoid Arthritis Drugs Sales, Revenue and Growth Rate of Others (2017-2022)

6 Global Rheumatoid Arthritis Drugs Market Analysis by Application
6.1 Global Rheumatoid Arthritis Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Rheumatoid Arthritis Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Rheumatoid Arthritis Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Rheumatoid Arthritis Drugs Consumption and Growth Rate of Prescription-Based Drugs (2017-2022)
6.3.2 Global Rheumatoid Arthritis Drugs Consumption and Growth Rate of Over-the-Counter Drugs (2017-2022)

7 Global Rheumatoid Arthritis Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Rheumatoid Arthritis Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Rheumatoid Arthritis Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Rheumatoid Arthritis Drugs Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Rheumatoid Arthritis Drugs Market Forecast (2022-2029)
8.1 Global Rheumatoid Arthritis Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Rheumatoid Arthritis Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Rheumatoid Arthritis Drugs Price and Trend Forecast (2022-2029)
8.2 Global Rheumatoid Arthritis Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Rheumatoid Arthritis Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Rheumatoid Arthritis Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate of Disease-Modifying Anti-Rheumatic Drugs (DMARDs) (2022-2029)
8.3.2 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2022-2029)
8.3.3 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate of Corticosteroids (2022-2029)
8.3.4 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate of Uric Acid Drugs (2022-2029)
8.3.5 Global Rheumatoid Arthritis Drugs Revenue and Growth Rate of Others (2022-2029)
8.4 Global Rheumatoid Arthritis Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Rheumatoid Arthritis Drugs Consumption Value and Growth Rate of Prescription-Based Drugs (2022-2029)
8.4.2 Global Rheumatoid Arthritis Drugs Consumption Value and Growth Rate of Over-the-Counter Drugs (2022-2029)
8.5 Rheumatoid Arthritis Drugs Market Forecast Under COVID-19

9 Industry Outlook
9.1 Rheumatoid Arthritis Drugs Market Drivers Analysis
9.2 Rheumatoid Arthritis Drugs Market Restraints and Challenges
9.3 Rheumatoid Arthritis Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Rheumatoid Arthritis Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Rheumatoid Arthritis Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Rheumatoid Arthritis Drugs Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Sodium Hyaluronate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 97
    Hyaluronic acid (HA) is a naturally occurring polymer found throughout The body. HA is vital for maintaining The function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection for Beauty industry and Therapy. The global Sodium Hyaluronate market was valued at US$ 357 million in 2023 and is anticipated to reach US$ 1237.4 million by 2030, witnessing a CAGR of 19.2% during The forecast period 2024-2030. Globa......
  • Global Sodium Hyaluronate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Sodium Hyaluronate market size was valued at US$ 349.2 million in 2023. With growing demand in downstream market, the Sodium Hyaluronate is forecast to a readjusted size of US$ 1245.4 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Sodium Hyaluronate market. Sodium Hyaluronate are expected to show stable growth in the future market. However, product ......
  • Global Osteoarthritis Pain Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 149
    According to our LPI (LP Information) latest study, the global Osteoarthritis Pain Drugs market size was valued at US$ 9601.5 million in 2023. With growing demand in downstream market, the Osteoarthritis Pain Drugs is forecast to a readjusted size of US$ 14350 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Osteoarthritis Pain Drugs market. Osteoarthritis Pain Drugs are expected to show stable growth in the futur......
  • Global Sodium Hyaluronate Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Sodium Hyaluronate market size was valued at USD 367.3 million in 2023 and is forecast to a readjusted size of USD 1196.4 million by 2030 with a CAGR of 18.4% during review period. Hyaluronic acid (HA) is a naturally occurring polymer found throughout the body. HA is vital for maintaining the function of healthy tissue, and can be used for a variety of applications.In this report we include Hyaluronic Acid Sodium Injection ......
  • Global Rheumatoid Arthritis Drug Professional Survey Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 3280 Onwards        Pages: 105
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Rheumatoid Arthritis Drug Market Research Report 2023, Forecast to 2028
    Published: 22-Dec-2023        Price: US 2680 Onwards        Pages: 162
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Sulfasalazine Market Research Report 2023, Forecast to 2028
    Published: 28-Nov-2023        Price: US 2680 Onwards        Pages: 165
    Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......
  • Global Sulfasalazine Professional Survey Report 2023, Forecast to 2028
    Published: 28-Nov-2023        Price: US 3280 Onwards        Pages: 131
    Sulfasalazine (SSZ), sold under the trade name Azulfidine among others, is a medication used to treat rheumatoid arthritis, ulcerative colitis, and Crohn's disease. It is considered by some to be a first-line treatment in rheumatoid arthritis. It is taken by mouth. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segme......
  • Global Osteoarthritis Pain Drugs Market Research Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 158
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs